OpenEvidence Withdraws Clinical AI Platform from UK and Europe Over Regulatory Uncertainty
Company valued at $12 billion cites unpredictable legal landscape as EU Artificial Intelligence Act creates compliance barriers for medical tool
By
Distilled Post Editorial Team